Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-022213

Options or other derivatives

  • Chief Financial Officer acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Radhakrishnan Karthik · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-07-01 Grant or award : show line 1 in the form Stock Options +125,000 125,000 D
Loading xslF345X05/rdgdoc.xml…